UnknownNot Applicable

LVSP Based CRT vs. RVAP Based CRT

China40 participantsStarted 2023-09-01

Plain-language summary

To find out whether left ventricular septal pacing (LVSP)-based cardiac resynchronization therapy (CRT) is superior to right ventricular apical pacing (RVAP)-based CRT in patients with failed left bundle branch pacing at the beginning of chronic heart failure.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Previous mechanical tricuspid valve replacement.
✕. Previous pacemaker or other devices implanted and for device replacement or upgrading for this time.
✕. Patients have a history of unstable angina, acute myocardial infarction, CABG, and PCI surgery within three months.
✕. Persistent atrial fibrillation without AV block, the proportion of biventricular pacing is not expected to less than 95%.
✕. Patients participated in any of the other studies at the same time, which may confound the results of this study.
✕. Pregnancy, planning to become pregnant.

What they're measuring

left ventricular ejection fraction (LVEF)

Timeframe: 6 months

left ventricular ejection fraction (LVEF)

Timeframe: 12 months

left ventricular end-systolic volume (LVESV)

Timeframe: 6 months

left ventricular end-systolic volume (LVESV)

Timeframe: 12 months

Trial details

NCT IDNCT05985408

SponsorFu Wai Hospital, Beijing, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Heart Failure trials